202 related articles for article (PubMed ID: 6097348)
1. [Presence of papillomavirus genomes and amplification of the c-myc and C-Ha-ras oncogenes in invasive cancers of the uterine cervix].
Riou G; Barrois M; Tordjman I; Dutronquay V; Orth G
C R Acad Sci III; 1984; 299(14):575-80. PubMed ID: 6097348
[TBL] [Abstract][Full Text] [Related]
2. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes.
Tate JE; Mutter GL; Prasad CJ; Berkowitz R; Goodman H; Crum CP
Gynecol Oncol; 1994 Apr; 53(1):78-83. PubMed ID: 8175026
[TBL] [Abstract][Full Text] [Related]
3. [Human papillomaviruses and cellular oncogenes (c-myc, c-Ha-ras) in cutaneous and mucosal lesions in transplantation recipients].
Pélisson I; Soler C; Chignol MC; Euvrard S; Chardonnet Y
Bull Cancer; 1992; 79(5):471-82. PubMed ID: 1330099
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of human papillomavirus type 16 DNA sequences and c-myc oncogene alterations in uterine-cervix carcinoma.
Ocádiz R; Sauceda R; Salcedo M; Ortega V; Rodríguez H; Gordillo C; Chávez P; Gariglio P
Arch Invest Med (Mex); 1989; 20(4):355-62. PubMed ID: 2562235
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis.
Ngan HY; Cheung AN; Liu SS; Cheng DK; Ng TY; Wong LC
Oncol Rep; 2001; 8(3):557-61. PubMed ID: 11295080
[TBL] [Abstract][Full Text] [Related]
6. [The possibility of viral etiology in cervical carcinogenesis].
Iwasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):802-11. PubMed ID: 2172417
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between human papillomavirus and oncogenes (c-myc, N-myc) amplification in human cervical cancers].
Kinoshita M; Ikei N; Shin S; Inui S; Hirao T; Aono T
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2828-35. PubMed ID: 1963632
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix.
Walker J; Bloss JD; Liao SY; Berman M; Bergen S; Wilczynski SP
Obstet Gynecol; 1989 Nov; 74(5):781-5. PubMed ID: 2554228
[TBL] [Abstract][Full Text] [Related]
9. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
[TBL] [Abstract][Full Text] [Related]
10. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
11. Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas.
Iwasaka T; Yokoyama M; Oh-uchida M; Matsuo N; Hara K; Fukuyama K; Hachisuga T; Fukuda K; Sugimori H
Gynecol Oncol; 1992 Sep; 46(3):298-303. PubMed ID: 1326470
[TBL] [Abstract][Full Text] [Related]
12. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
[TBL] [Abstract][Full Text] [Related]
13. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
14. A possible role for human papillomaviruses and c-myc, c-Ha-ras, and p53 gene alterations in malignant cutaneous lesions from renal transplant recipients.
Pelisson I; Soler C; Chardonnet Y; Euvrard S; Schmitt D
Cancer Detect Prev; 1996; 20(1):20-30. PubMed ID: 8907200
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of human papillomavirus types 16 and 18 DNA in cervical carcinomas from Japan: age of patients and histological type of carcinomas.
Yoshikawa H; Matsukura T; Yamamoto E; Kawana T; Mizuno M; Yoshiike K
Jpn J Cancer Res; 1985 Aug; 76(8):667-71. PubMed ID: 2995290
[TBL] [Abstract][Full Text] [Related]
16. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
17. The physical state of human papillomavirus type 16 DNA in cervical carcinomas of Hong Kong Chinese.
Yiu KC; Huang DP; Chan MK; Foo W
Oncogene; 1991 Aug; 6(8):1339-42. PubMed ID: 1653409
[TBL] [Abstract][Full Text] [Related]
18. Genomic organization of amplified MYC genes suggests distinct mechanisms of amplification in tumorigenesis.
Herrick J; Conti C; Teissier S; Thierry F; Couturier J; Sastre-Garau X; Favre M; Orth G; Bensimon A
Cancer Res; 2005 Feb; 65(4):1174-9. PubMed ID: 15735000
[TBL] [Abstract][Full Text] [Related]
19. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes.
Medina-Martínez O; Vallejo V; Guido MC; García-Carrancá A
Mol Carcinog; 1997 Jun; 19(2):83-90. PubMed ID: 9210955
[TBL] [Abstract][Full Text] [Related]
20. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
